Economy

Coffee, Flu Shots and Weight-Loss Surgery: How to Read This Week's Health Headlines

By EcoPress Newsroom · November 14, 2026 · 8 min read

A run of new studies links coffee to lower dementia risk, stronger flu shots to lower Alzheimer's risk, and bariatric surgery to more diabetes remission. Each deserves a careful look at what the research can and cannot show.

Health news moves quickly, and headlines tend to sound more certain than the studies behind them. Here are several recent findings and what kind of evidence stands behind each.

Coffee beans and a white mug
Coffee beans and a white mug. Illustrative image. Photo: Jessica Lewis, CC0, via Wikimedia Commons

Coffee and dementia

A study that followed people for up to 43 years linked two to three cups of coffee a day with a lower risk of dementia. This is observational research. It shows a pattern, not a cause. People who drink moderate coffee may differ in diet, income, sleep or exercise in ways that also affect the brain. It is a reason for interest, not a reason to start drinking coffee for your memory.

Flu shots and Alzheimer's

Another report suggests that a stronger flu vaccine for older adults may be associated with greater protection against Alzheimer's disease. Again, it is an association. Vaccinated people tend to be more engaged with health care generally. Researchers will need trials or more careful designs to separate the vaccine from the lifestyle around it. Flu shots are worth having for their direct benefits, particularly with this season's early start, which we covered in our flu season report.

Surgery versus medication for diabetes

A 14-year study found that weight-loss surgery produced more cases of type 2 diabetes remission than intensive medical management. This one is stronger evidence because of its length and its direct comparison of treatments, though surgery carries its own risks and is not right for everyone.

Early lab findings

Other items, such as an immune protein called perforin that may turn iron against cancer cells, or an implant that might lower blood sugar without insulin, were experiments in laboratory or early stages. Most promising results at that point do not reach patients. A zebrafish study from Memorial Sloan Kettering resolved a 30-year-old question about how cells guard against inflammation, which is valuable basic science but far from a treatment.

An outpatient waiting corridor at a hospital in Cameroon
An outpatient waiting corridor at a hospital in Cameroon. Illustrative image. Photo: Happi Raphael, CC BY-SA 4.0, via Wikimedia Commons

A good rule: ask who was studied, for how long, and whether the researchers compared people who received an intervention with people who did not. Then talk to a doctor before changing anything.

Also on EcoPress: FDA Orders an Eye-Risk Warning on Every GLP-1 Drug: What Patients Should Know · Early Flu Season 2026: H1N1 Hospital Admissions Climb

Sources and further reading: ScienceDaily health and medicine. Figures are as reported on the date of publication and may change.

Disclaimer: The information provided by EcoPress is for general informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. EcoPress does not recommend that any security, transaction, or investment strategy is suitable for any specific person. Readers should conduct their own research and consult with independent financial advisors before making any financial decisions. EcoPress is not responsible for any losses incurred as a result of using information published on this site.

About the Author

Leave a Comment

No comments yet.

Sponsored